{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T19:57:10Z","timestamp":1792526230584,"version":"4.5.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,15]],"date-time":"2021-11-15T00:00:00Z","timestamp":1636934400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004569","name":"Ministerstwo Edukacji i Nauki","doi-asserted-by":"publisher","award":["SUB.D190.20.004"],"award-info":[{"award-number":["SUB.D190.20.004"]}],"id":[{"id":"10.13039\/501100004569","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.ejpb.2021.11.001","type":"journal-article","created":{"date-parts":[[2021,11,13]],"date-time":"2021-11-13T17:41:58Z","timestamp":1636825318000},"page":"144-159","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"special_numbering":"C","title":["Binder jetting 3D printing of challenging medicines: From low dose tablets to hydrophobic molecules"],"prefix":"10.1016","volume":"170","author":[{"given":"Marta","family":"Kozakiewicz-Lata\u0142a","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karol P.","family":"Nartowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Dominik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Malec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna M.","family":"Go\u0142kowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrianna","family":"Z\u0142oci\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Rusi\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrycja","family":"Szymczyk-Zi\u00f3\u0142kowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grzegorz","family":"Zi\u00f3\u0142kowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agata","family":"G\u00f3rniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo\u017cena","family":"Karolewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2021.11.001_b0005","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1002\/jps.23146","article-title":"Three-dimensional printing in pharmaceutics: promises and problems","volume":"101","author":"Psimadas","year":"2012","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2021.11.001_b0010","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3390\/pharmaceutics11030128","article-title":"The digital pharmacies era: how 3D printing technology using fused deposition modeling can become a reality","volume":"11","author":"Ara\u00fajo","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2021.11.001_b0015","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3390\/pharmaceutics11070334","article-title":"Towards printed pediatric medicines in hospital pharmacies: comparison of 2D and 3D-printed orodispersible warfarin films with conventional oral powders in unit dose sachets","volume":"11","author":"\u00d6blom","year":"2019","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.ejpb.2021.11.001_b0020","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jconrel.2011.07.033","article-title":"Inkjet printing as a novel medicine formulation technique","volume":"156","author":"Scoutaris","year":"2011","journal-title":"J. Control. Release."},{"key":"10.1016\/j.ejpb.2021.11.001_b0025","unstructured":"ZipDose Technology | Spritam | Aprecia, (n.d.). https:\/\/www.aprecia.com\/technology\/zipdose (accessed January 7, 2021)."},{"issue":"1-2","key":"10.1016\/j.ejpb.2021.11.001_b0030","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ijpharm.2014.09.044","article-title":"Fused-filament 3D printing (3DP) for fabrication of tablets","volume":"476","author":"Goyanes","year":"2014","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.ejpb.2021.11.001_b0035","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.ijpharm.2015.10.039","article-title":"Fabrication of controlled-release budesonide tablets via desktop (FDM) 3D printing","volume":"496","author":"Goyanes","year":"2015","journal-title":"Int. J. Pharm."},{"issue":"1-2","key":"10.1016\/j.ejpb.2021.11.001_b0040","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ijpharm.2016.03.016","article-title":"Stereolithographic (SLA) 3D printing of oral modified-release dosage forms","volume":"503","author":"Wang","year":"2016","journal-title":"Int. J. Pharm."},{"issue":"1-2","key":"10.1016\/j.ejpb.2021.11.001_b0045","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ijpharm.2018.02.015","article-title":"Fabricating 3D printed orally disintegrating printlets using selective laser sintering","volume":"541","author":"Fina","year":"2018","journal-title":"Int. J. Pharm."},{"issue":"8","key":"10.1016\/j.ejpb.2021.11.001_b0050","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.drudis.2018.05.025","article-title":"Reshaping drug development using 3D printing","volume":"23","author":"Awad","year":"2018","journal-title":"Drug Discov. Today."},{"key":"10.1016\/j.ejpb.2021.11.001_b0055","doi-asserted-by":"crossref","unstructured":"H. Wickstr\u00f6m, E. Hilgert, J. Nyman, D. Desai, D. \u015een Karaman, T. de Beer, N. Sandler, J. Rosenholm, Inkjet Printing of Drug-Loaded Mesoporous Silica Nanoparticles\u2014A Platform for Drug Development, Molecules. 22 (2017) 2020. https:\/\/doi.org\/10.3390\/molecules22112020.","DOI":"10.3390\/molecules22112020"},{"key":"10.1016\/j.ejpb.2021.11.001_b0060","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.3390\/pharmaceutics12111034","article-title":"Electro-hydrodynamic drop-on-demand printing of aqueous suspensions of drug nanoparticles","volume":"12","author":"Elele","year":"2020","journal-title":"Pharmaceutics"},{"issue":"1-2","key":"10.1016\/j.ejpb.2021.11.001_b0065","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ijpharm.2013.11.021","article-title":"Desktop 3D printing of controlled release pharmaceutical bilayer tablets","volume":"461","author":"Khaled","year":"2014","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.ejpb.2021.11.001_b0070","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.ijpharm.2015.04.069","article-title":"Effect of geometry on drug release from 3D printed tablets","volume":"494","author":"Goyanes","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2021.11.001_b0075","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jconrel.2017.06.025","article-title":"3D inkjet printing of tablets exploiting bespoke complex geometries for controlled and tuneable drug release","volume":"261","author":"Kyobula","year":"2017","journal-title":"J. Control. Release."},{"key":"10.1016\/j.ejpb.2021.11.001_b0080","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jconrel.2015.09.028","article-title":"3D printing of five-in-one dose combination polypill with defined immediate and sustained release profiles","volume":"217","author":"Khaled","year":"2015","journal-title":"J. Control. Release."},{"issue":"2","key":"10.1016\/j.ejpb.2021.11.001_b0085","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.ijpharm.2015.07.067","article-title":"3D printing of tablets containing multiple drugs with defined release profiles","volume":"494","author":"Khaled","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2021.11.001_b0090","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jconrel.2020.02.046","article-title":"On-demand fully customizable drug tablets via 3D printing technology for personalized medicine","volume":"322","author":"Tan","year":"2020","journal-title":"J. Control. Release."},{"issue":"7","key":"10.1016\/j.ejpb.2021.11.001_b0095","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.3109\/03639045.2015.1120743","article-title":"3D Printing technologies for drug delivery: a review","volume":"42","author":"Prasad","year":"2016","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejpb.2021.11.001_b0100","doi-asserted-by":"crossref","unstructured":"C.J.H. Brenan, 3-D-Printed Pills: A New Age for Drug Delivery [From the Editor], IEEE Pulse. 6 (2015) 3\u20133. https:\/\/doi.org\/10.1109\/MPUL.2015.2456651.","DOI":"10.1109\/MPUL.2015.2456651"},{"issue":"10","key":"10.1016\/j.ejpb.2021.11.001_b0105","doi-asserted-by":"crossref","first-page":"3694","DOI":"10.1002\/jps.23678","article-title":"a step toward development of printable dosage forms for poorly soluble drugs","volume":"102","author":"Raijada","year":"2013","journal-title":"J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.ejpb.2021.11.001_b0110","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.ijpharm.2013.06.003","article-title":"Behavior of printable formulations of loperamide and caffeine on different substrates \u2013 effect of print density in inkjet printing","volume":"453","author":"Genina","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2021.11.001_b0115","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ejps.2018.01.036","article-title":"Inkjet printing of paracetamol and indomethacin using electromagnetic technology: rheological compatibility and polymorphic selectivity","volume":"115","author":"Kollamaram","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"issue":"8","key":"10.1016\/j.ejpb.2021.11.001_b0120","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.1002\/jps.22526","article-title":"Inkjet printing of drug substances and use of porous substrates-towards individualized dosing","volume":"100","author":"Sandler","year":"2011","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2021.11.001_b0125","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.ejpb.2015.08.012","article-title":"Combining inkjet printing and amorphous nanonization to prepare personalized dosage forms of poorly-soluble drugs","volume":"96","author":"Cheow","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2021.11.001_b0130","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ejps.2015.03.009","article-title":"Improvement of dissolution rate of indomethacin by inkjet printing","volume":"75","author":"Wickstr\u00f6m","year":"2015","journal-title":"Eur. J. Pharm. Sci."},{"issue":"7","key":"10.1016\/j.ejpb.2021.11.001_b0135","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1002\/jps.21189","article-title":"Thermal inkjet application in the preparation of oral dosage forms: dispensing of prednisolone solutions and polymorphic characterization by solid-state spectroscopic techniques","volume":"97","author":"Mel\u00e9ndez","year":"2008","journal-title":"J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.ejpb.2021.11.001_b0140","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/jps.23803","article-title":"Dropwise additive manufacturing of pharmaceutical products for solvent-based dosage forms","volume":"103","author":"Hirshfield","year":"2014","journal-title":"J. Pharm. Sci."},{"issue":"10","key":"10.1016\/j.ejpb.2021.11.001_b0145","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1007\/s11095-011-0450-5","article-title":"Preparation of personalized-dose salbutamol sulphate oral films with thermal ink-jet printing","volume":"28","author":"Buanz","year":"2011","journal-title":"Pharm. Res."},{"issue":"9","key":"10.1016\/j.ejpb.2021.11.001_b0150","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1081\/DDC-120025454","article-title":"Evaluation of critical formulation factors in the development of a rapidly dispersing captopril oral dosage form","volume":"29","author":"Lee","year":"2003","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejpb.2021.11.001_b0155","doi-asserted-by":"crossref","unstructured":"C.-C. Wang, M.R. Tejwani (Motwani), W.J. Roach, J.L. Kay, J. Yoo, H.L. Surprenant, D.C. Monkhouse, T.J. Pryor, Development of Near Zero-Order Release Dosage Forms Using Three-Dimensional Printing (3-DPTM) Technology, Drug Dev. Ind. Pharm. 32 (2006) 367\u2013376. https:\/\/doi.org\/10.1080\/03639040500519300.","DOI":"10.1080\/03639040500519300"},{"issue":"1-2","key":"10.1016\/j.ejpb.2021.11.001_b0160","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ijpharm.2008.12.008","article-title":"Novel drug delivery devices for providing linear release profiles fabricated by 3DP","volume":"370","author":"Yu","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2021.11.001_b0165","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1007\/s11595-009-6977-1","article-title":"The controlled-releasing drug implant based on the three dimensional printing technology: Fabrication and properties of","volume":"24","author":"Weigang","year":"2009","journal-title":"J. Wuhan Univ. Technol. Mater. Sci. Ed."},{"issue":"6","key":"10.1016\/j.ejpb.2021.11.001_b0170","doi-asserted-by":"crossref","first-page":"959","DOI":"10.3109\/03639045.2014.919314","article-title":"Dielectric spectroscopy for the determination of the glass transition temperature of pharmaceutical solid dispersions","volume":"41","author":"O\u2019Donnell","year":"2015","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejpb.2021.11.001_b0175","unstructured":"U. Payumo, Francis C. (Somerville, MA, US), Sherwood, Jill K. (Edison, NJ, US), Monkhouse, Donald C. (Radnor, PA, US), Yoo, Jaedeok (West Orange, NJ, US), Gaylo, Christopher M. (Princeton Junction, NJ, US), Wang, Chen-chao (West Windsor, NJ, US), Cima, Micha, Method and form of a drug delivery device, such as encapsulating a toxic core within a non-toxic region in an oral dosage form, 7875290, 2011."},{"key":"10.1016\/j.ejpb.2021.11.001_b0180","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1002\/jps.23146","article-title":"Thermal inkjet application in the preparation of oral dosage forms: dispensing of prednisolone solutions and polymorphic characterization by solid-state spectroscopic techniques PETER","volume":"101","author":"Psimadas","year":"2012","journal-title":"J. Pharm. Sci."},{"issue":"12","key":"10.1016\/j.ejpb.2021.11.001_b0185","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1021\/acs.oprd.9b00354","article-title":"Design and scale-up of a co-processing technology to improve powder properties of drug substances","volume":"23","author":"Erdemir","year":"2019","journal-title":"Org. Process Res. Dev."},{"issue":"3","key":"10.1016\/j.ejpb.2021.11.001_b0190","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.ejpb.2014.10.018","article-title":"Crystal coating via spray drying to improve powder tabletability","volume":"88","author":"Vanhoorne","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"12","key":"10.1016\/j.ejpb.2021.11.001_b0195","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1007\/s11095-011-0518-2","article-title":"Overcoming poor tabletability of pharmaceutical crystals by surface modification","volume":"28","author":"Shi","year":"2011","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2021.11.001_b0200","unstructured":"H.M. Bay, K. Thomas, Systems and processes for spray drying hydrophobic drugs with hydrophilic excipients, 2000."},{"key":"10.1016\/j.ejpb.2021.11.001_b0205","doi-asserted-by":"crossref","first-page":"10","DOI":"10.14805\/jphchem.2014.art8","article-title":"Method development and validation of hydrochlorothiazide and quinapril in bulk and tablet dosage form by RP-HPLC","volume":"1","author":"Kanchukommula","year":"2014","journal-title":"J. Pharm. Chem."},{"issue":"13","key":"10.1016\/j.ejpb.2021.11.001_b0210","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.14233\/ajchem.2014.15935","article-title":"Simultaneous estimation of quinapril hydrochloride and hydrochlorothiazide from pharmaceutical formulation by using UV, IR and RP-HPLC anti-hyperlipidemic and hypoglycemic agents view project","volume":"26","author":"Gawande","year":"2014","journal-title":"Artic Asian J. Chem."},{"key":"10.1016\/j.ejpb.2021.11.001_b0215","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.4314\/tjpr.v13i8.5","article-title":"Physicochemical characterization and dissolution studies of solid dispersions of clotrimazole with pluronic F127","volume":"13","author":"Karolewicz","year":"2014","journal-title":"Trop. J. Pharm. Res."},{"key":"10.1016\/j.ejpb.2021.11.001_b0220","doi-asserted-by":"crossref","first-page":"461","DOI":"10.4103\/0972-124X.118317","article-title":"Salivary pH: a diagnostic biomarker","volume":"17","author":"Baliga","year":"2013","journal-title":"J. Indian Soc. Periodontol."},{"issue":"1","key":"10.1016\/j.ejpb.2021.11.001_b0225","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0028-2243(91)90205-Y","article-title":"The vaginal pH and leucocyte\/epithelial cell ratio vary during normal menstrual cycles","volume":"38","author":"Larsson","year":"1991","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"2","key":"10.1016\/j.ejpb.2021.11.001_b0230","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ejps.2010.03.003","article-title":"Wettability and surface chemistry of crystalline and amorphous forms of a poorly water soluble drug","volume":"40","author":"Puri","year":"2010","journal-title":"Eur. J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.ejpb.2021.11.001_b0235","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0378-5173(00)00341-0","article-title":"Wettability studies of morphine sulfate powders","volume":"198","author":"Prestidge","year":"2000","journal-title":"Int. J. Pharm."},{"issue":"6","key":"10.1016\/j.ejpb.2021.11.001_b0240","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1021\/la0532407","article-title":"Anisotropic surface energetics and wettability of macroscopic form I paracetamol crystals","volume":"22","author":"Heng","year":"2006","journal-title":"Langmuir"},{"issue":"10","key":"10.1016\/j.ejpb.2021.11.001_b0245","doi-asserted-by":"crossref","first-page":"5283","DOI":"10.1021\/cg501084a","article-title":"Effect of crystal habit on intrinsic dissolution behavior of celecoxib due to differential wettability","volume":"14","author":"Modi","year":"2014","journal-title":"Cryst. Growth Des."},{"issue":"3","key":"10.1016\/j.ejpb.2021.11.001_b0250","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.ejpb.2013.03.017","article-title":"Evaluation of different substrates for inkjet printing of rasagiline mesylate","volume":"85","author":"Genina","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"49","key":"10.1016\/j.ejpb.2021.11.001_b0255","doi-asserted-by":"crossref","first-page":"13214","DOI":"10.1021\/acs.langmuir.6b01967","article-title":"Structure and Mobility of Lactose in Lactose\/Sodium Montmorillonite Nanocomposites","volume":"32","author":"Hellrup","year":"2016","journal-title":"Langmuir."},{"issue":"5","key":"10.1016\/j.ejpb.2021.11.001_b0260","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1021\/acs.cgd.5b00268","article-title":"Soluble Salts and Cocrystals of Clotrimazole","volume":"15","author":"Mittapalli","year":"2015","journal-title":"Cryst. Growth Des."},{"key":"10.1016\/j.ejpb.2021.11.001_b0265","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.saa.2018.12.047","article-title":"Structural activity, fungicidal activity and molecular dynamics simulation of certain triphenyl methyl imidazole derivatives by experimental and computational spectroscopic techniques","volume":"212","author":"Sheeja Mol","year":"2019","journal-title":"Spectrochim. Acta - Part A Mol. Biomol. Spectrosc."},{"issue":"1-2","key":"10.1016\/j.ejpb.2021.11.001_b0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2003.11.025","article-title":"Solid dispersion of carbamazepine in PVP K30 by conventional solvent evaporation and supercritical methods","volume":"272","author":"Sethia","year":"2004","journal-title":"Int. J. Pharm."},{"issue":"8","key":"10.1016\/j.ejpb.2021.11.001_b0275","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1039\/C9NA00186G","article-title":"The role of polyvinylpyrrolidone (PVP) as a capping and structure-directing agent in the formation of Pt nanocubes","volume":"1","author":"Safo","year":"2019","journal-title":"Nanoscale Adv."},{"issue":"1","key":"10.1016\/j.ejpb.2021.11.001_b0280","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.jmrt.2018.04.023","article-title":"Characterization and some physical studies of PVA\/PVP filled with MWCNTs","volume":"8","author":"Zidan","year":"2019","journal-title":"J. Mater. Res. Technol."},{"issue":"2","key":"10.1016\/j.ejpb.2021.11.001_b0285","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1021\/jm00106a005","article-title":"Molecular and Crystal Structures of MDL27,467A Hydrochloride and Quinapril Hydrochloride, Two Ester Derivatives of Potent Angiotensin Converting Enzyme Inhibitors","volume":"34","author":"Hausin","year":"1991","journal-title":"J. Med. Chem."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641121002745?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641121002745?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:46:17Z","timestamp":1760546777000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641121002745"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":57,"alternative-id":["S0939641121002745"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2021.11.001","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Binder jetting 3D printing of challenging medicines: From low dose tablets to hydrophobic molecules","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2021.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}